bioAffinity Technologies ...

0.27
0.15 (124.81%)
At close: Apr 17, 2025, 3:14 PM

bioAffinity Statistics

Share Statistics

bioAffinity has 15.58M shares outstanding. The number of shares has increased by 36.12% in one year.

Shares Outstanding 15.58M
Shares Change (YoY) 36.12%
Shares Change (QoQ) 15.52%
Owned by Institutions (%) n/a
Shares Floating 9.42M
Failed to Deliver (FTD) Shares 151
FTD / Avg. Volume 3.22%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

The PE ratio is undefined and the forward PE ratio is null. bioAffinity's PEG ratio is undefined.

PE Ratio undefined
Forward PE n/a
PS Ratio 5.08
Forward PS null
PB Ratio 2.65
P/FCF Ratio undefined
PEG Ratio undefined
Financial Ratio History

Enterprise Valuation

bioAffinity has an Enterprise Value (EV) of 11.62M.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of undefined.

Current Ratio 1.77
Quick Ratio 1.76
Debt / Equity undefined
Debt / EBITDA -
Debt / FCF -
Interest Coverage undefined

Financial Efficiency

Return on Equity is -1.63% and Return on Invested Capital is -124.25%.

Return on Equity -1.63%
Return on Assets -0.97%
Return on Invested Capital -124.25%
Revenue Per Employee $33.77K
Profits Per Employee $-105.83K
Employee Count 75
Asset Turnover 0.31
Inventory Turnover 94.18

Taxes

Income Tax 20.99K
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 240.14% in the last 52 weeks. The beta is 3.12, so bioAffinity's price volatility has been higher than the market average.

Beta 3.12
52-Week Price Change 240.14%
50-Day Moving Average 0.6
200-Day Moving Average 0.65
Relative Strength Index (RSI) 42.18
Average Volume (20 Days) 4.69K

Income Statement

In the last 12 months, bioAffinity had revenue of 2.53M and earned -7.94M in profits. Earnings per share was -0.91.

Revenue 2.53M
Gross Profit 791.62K
Operating Income -7.97M
Net Income -7.94M
EBITDA -7.63M
EBIT -7.97M
Earnings Per Share (EPS) -0.91
Full Income Statement

Balance Sheet

The company has 2.82M in cash and 1.58M in debt, giving a net cash position of 1.24M.

Cash & Cash Equivalents 2.82M
Total Debt 1.58M
Net Cash 1.24M
Retained Earnings -44.6M
Total Assets 6.55M
Working Capital 57.97K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.04M and capital expenditures -22.9K, giving a free cash flow of -6.06M.

Operating Cash Flow -6.04M
Capital Expenditures -22.9K
Free Cash Flow -6.06M
FCF Per Share -0.69
Full Cash Flow Statement

Margins

Gross margin is 31.26%, with operating and profit margins of -314.84% and -313.41%.

Gross Margin 31.26%
Operating Margin -314.84%
Pretax Margin -312.58%
Profit Margin -313.41%
EBITDA Margin -301.26%
EBIT Margin -314.84%
FCF Margin -239.32%

Dividends & Yields

BIAFW does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -260%
FCF Yield -111.11%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for BIAFW.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -12.63
Piotroski F-Score 2